The Clinical Services and Diagnostics Core of the proposed Center represents a unique resource that is organized around the recruitment, characterization and rigorous diagnostic evaluation of first-episode, antipsychotic-naive schizophrenia and non-schizophrenia psychotic subjects, and healthy controls, and the acquisition of clinical data and diagnoses of subjects used in postmortem studies. Clinical research studies conducted in the proposed Center will use multimodal electrophysiological methods, functional neuroimaging (fMRI) approaches (Project 5-Phillips), and a novel PET method (Project 6-Mathis) to test hypotheses regarding the relationships between cortical neuronal network activity, GABA neurotransmission and information processing deficits in schizophrenia. The Core integrates and coordinates the recruitment and assessment of subjects across projects within the proposed Center as well as for other funded collaborative projects to ensure that subjects are efficiently and productively engaged with a minimum redundancy of activities. The clinical and diagnostic expertise of Core faculty and staff is also utilized in the characterization of the clinical research diagnoses of individuals whose post-mortem brain specimens are used in Project 1- Lewis. The infrastructure of the Clinical Services and Diagnostics Core also serves as an educational opportunity for young investigators to develop seed proposals to address questions relating to the pathophysiology of schizophrenia, and as a means to educate the practicing clinicians, students, and the general public about advances in schizophrenia research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
3P50MH084053-05S1
Application #
8500453
Study Section
Special Emphasis Panel (ZMH1-ERB-S)
Project Start
Project End
2013-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
5
Fiscal Year
2012
Total Cost
$51,863
Indirect Cost
$7,919
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Lizano, Paulo L; Yao, Jeffrey K; Tandon, Neeraj et al. (2017) Association of sFlt-1 and worsening psychopathology in relatives at high risk for psychosis: A longitudinal study. Schizophr Res 183:75-81
Agrawal, A; Chou, Y-L; Carey, C E et al. (2017) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry :
Mancuso, Nicholas; Shi, Huwenbo; Goddard, Pagé et al. (2017) Integrating Gene Expression with Summary Association Statistics to Identify Genes Associated with 30 Complex Traits. Am J Hum Genet 100:473-487
Jasinska, Anna J; Zelaya, Ivette; Service, Susan K et al. (2017) Genetic variation and gene expression across multiple tissues and developmental stages in a nonhuman primate. Nat Genet 49:1714-1721
Lewis, David A; Glausier, Jill R (2016) Alterations in Prefrontal Cortical Circuitry and Cognitive Dysfunction in Schizophrenia. Nebr Symp Motiv 63:31-75
Georgiev, Danko; Yoshihara, Toru; Kawabata, Rika et al. (2016) Cortical Gene Expression After a Conditional Knockout of 67 kDa Glutamic Acid Decarboxylase in Parvalbumin Neurons. Schizophr Bull 42:992-1002
Lizano, Paulo L; Keshavan, Matcheri S; Tandon, Neeraj et al. (2016) Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study. Schizophr Res 170:115-22
Li, Ming; Jaffe, Andrew E; Straub, Richard E et al. (2016) A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus. Nat Med 22:649-56
Kimoto, Sohei; Glausier, Jill R; Fish, Kenneth N et al. (2016) Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia. Schizophr Bull 42:396-405
Fromer, Menachem; Roussos, Panos; Sieberts, Solveig K et al. (2016) Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci 19:1442-1453

Showing the most recent 10 out of 98 publications